Recursion director receives stock grant under policy
Li Dean Y reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Li Dean Y reported acquisition or exercise transactions in this Form 4 filing.
RECURSION PHARMACEUTICALS, INC. director Dean Y. Li received a grant of 3,268 shares of Class A Common Stock at $0.0000 per share. The shares were issued under the company’s Outside Director Compensation Policy, reflecting equity-based compensation rather than an open-market purchase.
Following this grant, Li directly owns 1,244,177 Class A shares. He also has indirect ownership through several entities, including the Dean Y. Li Revocable Trust, the Dean Y. Li GRAT, and the Dean Y. Li 2021 Family Trust, each with separately reported share balances.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 3,268 shares
Grant/Award
4 txns
Insider
Li Dean Y
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 3,268 | $0.00 | $0.00 |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Holdings After Transaction:
Class A Common Stock — 1,244,177 shares (Direct);
Class A Common Stock — 1,422,048 shares (Indirect, By Dean Y. Li Revocable Trust);
Class A Common Stock — 136,981 shares (Indirect, By Dean Y. Li GRAT);
Class A Common Stock — 421,000 shares (Indirect, By Dean Y. Li 2021 Family Trust)
Footnotes (1)
- F1. The shares were issued pursuant to the Issuer's Outside Director Compensation Policy.
Key Figures
Stock grant: 3,268 shares
Grant price: $0.0000 per share
Direct holdings after grant: 1,244,177 shares
+3 more
6 metrics
Stock grant
3,268 shares
Class A Common Stock granted to director on 2026-04-01
Grant price
$0.0000 per share
Price for 3,268-share award under Outside Director Compensation Policy
Direct holdings after grant
1,244,177 shares
Dean Y. Li direct Class A Common Stock position following transaction
Revocable Trust holdings
1,422,048 shares
Class A Common Stock held indirectly by Dean Y. Li Revocable Trust
GRAT holdings
136,981 shares
Class A Common Stock held indirectly by Dean Y. Li GRAT
2021 Family Trust holdings
421,000 shares
Class A Common Stock held indirectly by Dean Y. Li 2021 Family Trust
Key Terms
Outside Director Compensation Policy, Grant, award, or other acquisition, Revocable Trust, GRAT, +1 more
5 terms
Outside Director Compensation Policy financial
"The shares were issued pursuant to the Issuer's Outside Director Compensation Policy."
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
Revocable Trust financial
"nature_of_ownership: By Dean Y. Li Revocable Trust"
A revocable trust is a legal arrangement where the person who creates it keeps control and can change or cancel the trust at any time, while naming who will manage and receive the assets later. Think of it like a flexible folder for your investments and property that can be relabeled or reworked as circumstances change; it matters to investors because it determines how ownership is recorded, how easily assets transfer on incapacity or death, and whether holdings bypass public probate proceedings.
GRAT financial
"nature_of_ownership: By Dean Y. Li GRAT"
Family Trust financial
"nature_of_ownership: By Dean Y. Li 2021 Family Trust"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did RXRX director Dean Y. Li report in this Form 4?
Dean Y. Li reported receiving 3,268 shares of Recursion Class A Common Stock. The shares were issued at $0.0000 per share under the Outside Director Compensation Policy, increasing his directly held position while reflecting routine equity compensation for board service.
Is the RXRX Form 4 transaction a stock purchase or a grant?
The Form 4 shows a stock grant, not an open-market purchase. Code A indicates a grant or award, and footnotes state the 3,268 Class A shares were issued under Recursion’s Outside Director Compensation Policy at $0.0000 per share as equity compensation.
What indirect RXRX holdings are reported for Dean Y. Li?
Indirect holdings are reported through three entities: the Dean Y. Li Revocable Trust with 1,422,048 shares, the Dean Y. Li GRAT with 136,981 shares, and the Dean Y. Li 2021 Family Trust with 421,000 shares, each listed separately as indirect ownership entries.
What does the Outside Director Compensation Policy mean for RXRX insiders?
The Outside Director Compensation Policy provides equity awards to non-employee directors. In this filing, Recursion granted 3,268 Class A shares at $0.0000 per share to director Dean Y. Li, illustrating how the policy compensates board members using company stock instead of cash.
AI-generated analysis. How Rhea-AI works. Not financial advice.
